| 标题 |
Overall survival in patients with hormone receptor-positive, HER2-negative advanced breast cancer treated in a phase 1b trial evaluating gedatolisib in combination with palbociclib and endocrine therapy |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Rachel M. Layman; Hyo S. Han; Hope S. Rugo; Erica Stringer-Reasor; Jennifer M. Specht; et al 出版日期:2025-07-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)